The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately. The price is down 15% over the past year, to $3.73 per unit.
Market view
cefepime hydrochloride · Injection, Powder, For Solution
9 marketed package NDCs · 3 active manufacturers
Most dispensed: 2 g/20mL · Injection, Powder, For Solution · #10 vials/carton / 20 ml in 1 vial · 1 g/20mL · Injection, Powder, For Solution · #10 vials/carton / 20 ml in 1 vial · 2 g · Injection, Powder, For Solution · #10 vials/carton / 1 injection, powder, for solution in 1 vial · 1 g · Injection, Powder, For Solution · #10 vials/carton / 1 injection, powder, for solution in 1 vial
Price range and competition
RSS: changes for this drugEvery company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.
Latest · Feb 2026 — typical price $3.73 · middle half $3.73–$3.73 · full range $3.73–$3.73 · 1 products · 3 companies
ⓘ How this was built
Data sources
- CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
- CMS Federal Upper Limit files (weighted AMP)
- FDA NDC Directory (openFDA) — maker roster
Method
Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
What changed in the last 90 days
Every detected change for cefepime hydrochloride, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Same drug class
Other molecules FDA puts in Cephalosporin Antibacterial, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- cefotaxime· in shortage
- cefotaxime injection· in shortage
- ceftazidime, avibactam· 1 maker
- ceftobiprole medocaril sodium· 1 maker
- ceftolozane and tazobactam· 1 maker
- cefuroxime· 1 maker
- cefuroxime and dextrose· 1 maker
- zidebactam dihydrate and cefepime hydrochloride· 1 maker
- cefiderocol sulfate tosylate· 2 makers
- cefotetan· 2 makers
- cefotetan disodium· 2 makers
- ceftaroline fosamil· 2 makers
Common questions
- Is Cefepime hydrochloride in shortage right now?
- No. FDA does not currently list Cefepime hydrochloride in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Cefepime hydrochloride?
- 5 companies have marketed Cefepime hydrochloride in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.